Partner Mike Fuller was quoted in, “This Shield of Patents Protects the World’s Best-Selling Drug,” an article published in Bloomberg Businessweek.
Excerpt: The more than 100 patents AbbVie has secured over Humira’s lifetime make it difficult for another company to replicate the drug without using processes and techniques to which the pharma giant continues to hold rights.
Read Full Article Here >> (Subscription required)
